Yale Cancer Center Smilow Cancer Hospital

New Haven, Connecticut 06520

3 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Glioblastoma, HER2-negative Breast Cancer, Hyperinsulinism

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma — Recruiting now
• Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy — Recruiting now